ArticleJournal of the Endocrine Society2024

Semaglutide Concurrently Improves Vascular and Liver Indices in Patients With Type 2 Diabetes and Fatty Liver Disease.

Emmanouil Korakas et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.